Kohlberg

We are pleased to announce the successful closing of our strategic reinvestment in PCI Pharma Services. Since Kohlberg’s lead #investment in 2020, PCI has transformed into a leading global CDMO, and we are proud of the accelerated #growth it has achieved and the critical role it plays in the biopharmaceutical supply chain. We look forward to supporting CEO Salim Haffar and Chairman Matt Jennings as the company enters its next chapter of advancement, meets the future demands of biopharmaceutical customers, and enables clients around the world to bring life-changing therapies to market. 

We are pleased to welcome veteran CRO leader Alistair Macdonald as Chief Executive Officer of Kohlberg portfolio company Worldwide Clinical Trials.   Since we invested in Worldwide in 2023, the company has further solidified its position as a full-service CRO, investing boldly in technology, expanding its capabilities, and scaling globally.   With proven growth leader Alistair Macdonald as CEO, supported by Matt Jennings, Executive Chairman and Kohlberg Operating Partner, we are confident Worldwide will further accelerate its impressive trajectory to meet the evolving needs of customers and patients.

Proud to welcome Bronx Lacrosse students to our offices for an inspiring conversation on careers, college, and the world of finance.

Excited to share Kohlberg’s strategic reinvestment in PCI Pharma Services in partnership with our new co-control investor Bain Capital plus continuing investors Mubadala and Partners Group. Also excited as the company enters its next phase of growth continuing to work with PCI CEO Salim Haffar and Chairman Matt Jennings. Since our lead investment in PCI in 2020, PCI has: ➡️Expanded into biologics, sterile fill-finish services for injectable drugs, and Advanced Drug Delivery, extending the company into the highest growth markets in pharma CDMO ➡️Invested organically and inorganically, including in cold chain infrastructure, regional facilities to support customers’ needs globally, and Advanced Drug Delivery injectable capabilities  ➡️Launched 450 drugs, now supporting 25% of the top 200 drugs on the market, including GLP-1s ➡️Doubled revenue, 4x’d its customer base, and grew from 3,000 to 8,000 employees ➡️Modernized through digital innovation, automation, and smart manufacturing ➡️Invested in its people, processes, and purpose-built facilities to meet growing global demand PCI today delivers an integrated state-of-the-art suite of modernized services from Phase 1 through commercial launch, spanning sterile fill-finish, drug delivery assembly, packaging, and global logistics. We look forward to supporting PCI as it continues to bring life-changing therapies to patients. 🔗 Full press release and details available here: https://lnkd.in/d8_2fzfp

Kohlberg is pleased to announce a majority investment in RESA Power, a premier provider of power systems and solutions across North America. Since its founding in 2003, RESA has grown into a leading provider of mission-critical maintenance, testing, and systems integration for electrical infrastructure across North America. RESA is well-positioned to capitalize on growing demand for power services and the need for greater grid resiliency with more than 50 service locations serving the critical infrastructure services sector. We look forward to partnering with the RESA management team, and leveraging our many years of expertise in infrastructure services, to accelerate the Company’s growth, expand its capabilities, and deliver even greater value to its customers. Read the full announcement here: https://lnkd.in/gEHsfYhR #PrivateEquity #Infrastructure #PowerSystems #ElectricalServices #Investing

Kohlberg & Company is proud to announce the sale of a majority stake in GPRS, a leading provider of subsurface infrastructure and facility management solutions for utilities, contractors, and engineering customers across the United States.   Since 2020, under Kohlberg’s ownership, GPRS recruited significant talent, executed six acquisitions, and drove increased market penetration with new and existing customers, among other initiatives, to achieve above-market growth.   We are pleased to remain a minority investor in the company alongside new majority owner Roark Capital, and look forward to continuing our strategic partnership with GPRS’ management team.   Read the full announcement here: https://lnkd.in/dB7JkZnA   #PrivateEquity #Investing #Engineering #Infrastructure

Congratulations to Kohlberg & Company portfolio company AWP Safety, North America's leading provider of safety and traffic management solutions, on its strategic acquisition of three regional, full-service traffic control companies: Site Barricades, Integrity Traffic, LLC and WS Barricade. Kohlberg is proud to leverage our deep sector research and targeted execution ability, in partnership with AWP Safety’s management team, to further enhance the business as it continues to expand its existing footprint. These acquisitions strengthen the company’s position as North America's preferred safety partner in the utility, broadband and roadway infrastructure space, and further reinforce AWP Safety’s established leadership in traffic control services, planning, and installation. #PrivateEquity #Acquisition #TrafficManagement #Safety

We are pleased to announce the acquisition of Maskwa High Voltage Ltd. by ENTRUST Solutions Group, a Kohlberg & Company portfolio company. The addition of Maskwa’s Canadian transmission and substation services business will enable ENTRUST to continue to grow both its geographic footprint and service offerings across key energy infrastructure engineering markets. We look forward to continuing to support ENTRUST’s capable management team as they further enhance the business and execute on the company’s ongoing strategic growth initiatives in 2025. Read the full announcement below. #PrivateEquity #Acquisition #Energy #Infrastructure